According to Swedish Orphan Biovitrum's latest financial reports the company's current EPS (TTM) is โน59.64. In 2022 the company made an earnings per share (EPS) of โน57.46 a decrease over its 2021 EPS that were of โน85.33.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน57.57 | 0.2% |
2022 | โน57.46 | -32.67% |
2021 | โน85.33 | -16.9% |
2020 | โน102.68 | 2.54% |
2019 | โน100.14 | 19.37% |
2018 | โน83.89 | 98.42% |
2017 | โน42.28 | 41.84% |
2016 | โน29.81 | 1227.12% |
2015 | โน2.25 | -117.81% |
2014 | -โน12.61 | 184.25% |
2013 | -โน4.44 | -12.81% |
2012 | -โน5.09 | -433.93% |
2011 | โน1.52 | -126.14% |
2010 | -โน5.83 | -258.4% |
2009 | โน3.68 |